Price T Rowe Associates Inc Codexis, Inc. Transaction History
Price T Rowe Associates Inc
- $869 Billion
- Q3 2024
A detailed history of Price T Rowe Associates Inc transactions in Codexis, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 22,720 shares of CDXS stock, worth $104,739. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,720
Previous 20,794
9.26%
Holding current value
$104,739
Previous $65,000
7.69%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding CDXS
# of Institutions
125Shares Held
59.9MCall Options Held
25.9KPut Options Held
20.1K-
Opaleye Management Inc. Boston, MA8.77MShares$40.4 Million4.93% of portfolio
-
Casdin Capital, LLC New York, NY8.1MShares$37.3 Million1.94% of portfolio
-
Black Rock Inc. New York, NY6.79MShares$31.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.15MShares$19.1 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.97MShares$13.7 Million0.54% of portfolio
About CODEXIS, INC.
- Ticker CDXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,494,100
- Market Cap $302M
- Description
- Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...